Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01404585
What this trial is testing

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 123
Large-scale testing (Phase 3)Study completedNCT01436149
What this trial is testing

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Shire 1,262
Post-approval studies (Phase 4)Study completedNCT03449758
What this trial is testing

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sanofi 84
Testing effectiveness (Phase 2)Study completedNCT03472885
What this trial is testing

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria With Inadequate Response to Eculizumab

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Alexion Pharmaceuticals, Inc. 12
Testing effectiveness (Phase 2)Study completedNCT01405911
What this trial is testing

Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105)

Who this might be right for
Glucose Intolerance
Merck Sharp & Dohme LLC 242
Post-approval studies (Phase 4)Study completedNCT00576433
What this trial is testing

MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 60
Large-scale testing (Phase 3)Study completedNCT00502840
What this trial is testing

Re-Treatment With MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor.

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 193
Testing effectiveness (Phase 2)Study completedNCT01554696
What this trial is testing

Evaluate the Safety and Efficacy of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Arthritis, Rheumatoid
Astellas Pharma Inc 379
Post-approval studies (Phase 4)UnknownNCT01829685
What this trial is testing

Efficacy Optimizing Extension Study of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

Who this might be right for
Chronic Hepatitis BInadequate ResponseNucleos(t)Ide Analogues Treatment
Nanfang Hospital, Southern Medical University 360
Large-scale testing (Phase 3)Study completedNCT00235885
What this trial is testing

Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic Arthritis
Abbott 445
Not applicableLooking for participantsNCT07175285
What this trial is testing

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Bristol-Myers Squibb 223
Testing effectiveness (Phase 2)Study completedNCT01234558
What this trial is testing

Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression

Who this might be right for
Major Depressive Disorder
Naurex, Inc, an affiliate of Allergan plc 115
Large-scale testing (Phase 3)Study completedNCT03602560
What this trial is testing

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Who this might be right for
Primary Biliary Cholangitis
Gilead Sciences 265
Testing effectiveness (Phase 2)Study completedNCT01912196
What this trial is testing

Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
MSI Methylation Sciences, Inc. 376
Large-scale testing (Phase 3)Ended earlyNCT00611455
What this trial is testing

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 265
Testing effectiveness (Phase 2)Study completedNCT04604652
What this trial is testing

Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis

Who this might be right for
Primary Biliary CholangitisPrimary Biliary CirrhosisCholangitis+3 more
HighTide Therapeutics (Hong Kong) Limited 24
Large-scale testing (Phase 3)Study completedNCT00326105
What this trial is testing

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders

Who this might be right for
Major Depressive Disorder
AstraZeneca 450
Large-scale testing (Phase 3)Study completedNCT01001832
What this trial is testing

Efficacy, Pharmacokinetics, Safety, and Immunogenicity Study of Abatacept Administered Subcutaneously to Treat Rheumatoid Arthritis in Japanese Patients

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 118
Testing effectiveness (Phase 2)Study completedNCT01435759
What this trial is testing

SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Shire 1,197
Large-scale testing (Phase 3)Study completedNCT01326962
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNF

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 28
Next Page